Interestingly, earlier studies have shown that overexpression of Hox genes or NCAM1 is linked with either a NE-like transformation or the development of AR signaling inhibitor-resistant prostate cancer(11, 29–31). The gene discussed is AR; the disease is prostate carcinoma.